Gradient Investments LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$15,130
+101.5%
978
+104.6%
0.00%
Q2 2023$7,509
-4.7%
4780.0%0.00%
Q1 2023$7,877
+5.6%
4780.0%0.00%
Q4 2022$7,457
+24.3%
4780.0%0.00%
Q3 2022$6,000
-14.3%
4780.0%0.00%
Q2 2022$7,0000.0%4780.0%0.00%
Q1 2022$7,0000.0%4780.0%0.00%
Q4 2021$7,000
-12.5%
4780.0%0.00%
Q3 2021$8,0000.0%4780.0%0.00%
Q2 2021$8,000
-11.1%
4780.0%0.00%
Q1 2021$9,0000.0%4780.0%0.00%
Q4 2020$9,0000.0%4780.0%0.00%
Q3 2020$9,000
-30.8%
478
-32.3%
0.00%
-100.0%
Q2 2020$13,000
+85.7%
706
+47.7%
0.00%
Q1 2020$7,000
-22.2%
4780.0%0.00%
Q4 2019$9,000
+12.5%
4780.0%0.00%
Q3 2019$8,0000.0%4780.0%0.00%
Q2 2019$8,000
-20.0%
4780.0%0.00%
-100.0%
Q1 2019$10,000
+100.0%
478
+67.1%
0.00%
Q4 2018$5,0002860.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders